Having elucidated the molecular mechanism by which SCP3 activation promotes tumor growth via the AKT pathway, we next examined SCP3 and pAKT protein expression levels by immunohistochemistry in cervical tissue specimens from patients with CIN or invasive cervical cancer. The gene discussed is SYCP3; the disease is cervical carcinoma.